Regulatory And Quality Control Perspective

How High Is the Compliance Threshold for Injection Needle Manufacturers Under the Dual Tracks of ISO 7864 and FDA 510(k)?

Hypodermic needles are classified as Class II medical devices in the United States or IIa/IIb under the EU MDR. This may seem more lenient than implants, but the actual compliance cost is quite substantial-for a needle tube production line approved by the FDA, the verification documentation alone is often measured by the cabinet.

Three Major Standard Anchors

• ISO 7864:2016​ - Sterile hypodermic needles for single use, currently the internationally accepted "constitution" for needle tubes, specifying core indicators such as dimensional tolerances of needle tubes (outer diameter at ±0.02mm level), puncture force, connection firmness, and biocompatibility.
• ISO 9626​ - Specifically targets the "stainless steel needle tube material for medical use." During factory audits, purchasers should request the manufacturer's raw material certificate for 9626, not just the 7864 finished product report.
• FDA 510(k)​ - The U.S. market access pathway. Most needle tubes follow the "substantial equivalence" (predicate device) route, but after the implementation of MDR, many Chinese manufacturers were forced to supplement Clinical Evaluation Reports (CER), causing single-project budgets to jump from 300,000 RMB to over 800,000 RMB.

Sterilization and Particulate Control Are Trouble Zones

EO sterilization is currently the mainstream method for needle tubes, but EO residue (≤10μg/device) and 2-chloroethanol residue are high-frequency pitfalls in FDA Warning Letters. Another hidden minefield is particulate contamination-ISO 7886 requires that the number of particles ≥10μm in simulated post-use liquid does not exceed certain limits. Old production lines easily exceed standards due to "needle tip burrs + falling packaging fibers." Leading manufacturers add a step of "electropolishing" or "laser deburring" after needle tip cutting, rather than relying solely on visual full inspection.

Traceability and UDI

The EU MDR mandates UDI-DI coding at the needle tube level and requires connection to the Eudamed database. This means manufacturers must not only implement "one code per box" but also trace back to "which coil of stainless steel tube, which wire drawing machine, which shift." Currently, fewer than 20 needle tube factories in China can achieve batch-level reverse traceability.

During factory audits, focus on three areas:​ ① Needle tip microscope sampling inspection records (whether 100% visual inspection + AOI re-inspection); ② Frequency of third-party reports for EO residue; ③ Whether the UDI database is actually connected rather than merely labeling. If these three points fail, be cautious even if the certificates look impeccable.